Lipitor Market Share Is 10 Points Ahead Of Competitors, Pfizer Says
Executive Summary
Pfizer/Warner-Lambert's Lipitor "attained a 34.4% market share of U.S. new prescriptions of cholesterol-lowering agents in the week ending June 26, 1998, more than 10 percentage points ahead of any other product," according to Pfizer.